Holen Sie sich die Stockscreener-App
20.20
0.98%
0.2157
Schlusskurs vom Vortag:
$19.98
Offen:
$20.3
24-Stunden-Volumen:
3.43M
Relative Volume:
0.50
Marktkapitalisierung:
$19.26B
Einnahmen:
$8.35B
Nettoeinkommen (Verlust:
$-594.51M
KGV:
-32.23
EPS:
-0.6267
Netto-Cashflow:
$-3.55B
1W Leistung:
+16.48%
1M Leistung:
+12.46%
6M Leistung:
-3.33%
1J Leistung:
-20.41%
1-Tages-Spanne:
$20.01
$20.48
1-Wochen-Bereich:
$17.91
$20.48
52-Wochen-Spanne:
$15.38
$28.23
Xpeng Inc Adr Stock (XPEV) Company Profile
Firmenname
Xpeng Inc Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare XPEV vs TSLA, TM, GM, RACE, F
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XPEV
Xpeng Inc Adr
|
20.19 | 19.06B | 8.35B | -594.51M | -3.55B | -0.6267 |
|
TSLA
Tesla Inc
|
395.54 | 1.48T | 94.83B | 3.86B | 6.22B | 1.076 |
|
TM
Toyota Motor Corporation Adr
|
211.34 | 282.29B | 337.18B | 25.73B | 300.48M | 18.92 |
|
GM
General Motors Company
|
72.74 | 66.40B | 185.02B | 2.78B | 1.77B | 3.0106 |
|
RACE
Ferrari N V
|
333.40 | 59.20B | 8.07B | 1.81B | 1.64B | 10.10 |
|
F
Ford Motor Co
|
11.77 | 48.03B | 187.27B | -8.16B | 12.47B | -1.9158 |
Xpeng Inc Adr Stock (XPEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2025-08-18 | Eingeleitet | BNP Paribas Exane | Neutral |
| 2025-06-17 | Hochstufung | Goldman | Neutral → Buy |
| 2025-05-21 | Hochstufung | Macquarie | Neutral → Outperform |
| 2025-03-19 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2025-03-19 | Hochstufung | Nomura | Neutral → Buy |
| 2025-03-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-02-24 | Hochstufung | UBS | Sell → Neutral |
| 2025-02-07 | Herabstufung | Macquarie | Outperform → Neutral |
| 2024-12-05 | Herabstufung | UBS | Neutral → Sell |
| 2024-11-22 | Hochstufung | China Renaissance | Hold → Buy |
| 2024-11-21 | Herabstufung | Goldman | Buy → Neutral |
| 2024-09-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-08-30 | Hochstufung | Macquarie | Neutral → Outperform |
| 2024-06-25 | Hochstufung | Citigroup | Sell → Neutral |
| 2024-05-23 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-04-15 | Fortgesetzt | Macquarie | Neutral |
| 2023-08-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-08-08 | Hochstufung | CLSA | Outperform → Buy |
| 2023-08-07 | Hochstufung | HSBC Securities | Hold → Buy |
| 2023-07-31 | Herabstufung | UBS | Buy → Neutral |
| 2023-07-27 | Hochstufung | Jefferies | Hold → Buy |
| 2023-07-27 | Hochstufung | Macquarie | Underperform → Outperform |
| 2023-07-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-07-11 | Eingeleitet | Goldman | Buy |
| 2023-06-30 | Herabstufung | CLSA | Buy → Outperform |
| 2023-05-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-04-25 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-24 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-02-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-01-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-14 | Herabstufung | Daiwa Securities | Buy → Sell |
| 2022-11-28 | Herabstufung | Jefferies | Hold → Underperform |
| 2022-11-17 | Hochstufung | UBS | Neutral → Buy |
| 2022-10-28 | Herabstufung | Citigroup | Buy → Sell |
| 2022-08-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-08-03 | Herabstufung | Macquarie | Outperform → Neutral |
| 2022-07-01 | Herabstufung | Nomura | Buy → Neutral |
| 2022-05-25 | Eingeleitet | Macquarie | Outperform |
| 2022-04-01 | Eingeleitet | HSBC Securities | Buy |
| 2022-03-24 | Eingeleitet | China Renaissance | Buy |
| 2022-03-23 | Eingeleitet | CLSA | Buy |
| 2022-02-08 | Eingeleitet | Barclays | Overweight |
| 2022-01-12 | Eingeleitet | Macquarie | Outperform |
| 2021-10-28 | Eingeleitet | Bernstein | Outperform |
| 2021-05-26 | Eingeleitet | Nomura | Buy |
| 2021-03-09 | Hochstufung | Daiwa Securities | Sell → Buy |
| 2021-01-29 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-01-19 | Eingeleitet | Jefferies | Hold |
| 2020-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2020-12-03 | Herabstufung | UBS | Buy → Neutral |
| 2020-11-04 | Eingeleitet | Citigroup | Buy |
| 2020-09-25 | Eingeleitet | UBS | Buy |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-21 | Eingeleitet | BofA Securities | Buy |
Alle ansehen
Xpeng Inc Adr Aktie (XPEV) Neueste Nachrichten
Why Xpeng Stock Was Winning This Week - The Globe and Mail
Volkswagen Begins Mass Production for 1st Car Developed with XPENG-W - AASTOCKS.com
XPENG (XPEV) Projected to Post Earnings on Friday - MarketBeat
Stellantis Said to Be Interested in Bringing CN Automakers into European Biz, Once Holds Talks with XIAOMI-W/ XPENG-W - AASTOCKS.com
XPeng to Launch VLA 2.0 Autonomous Driving Platform in 2027 - TradingView
CMSI Optimistic About XPENG-W (09868.HK) Smart Driving Segment, Keeps Overweight Rating - AASTOCKS.com
XPeng (XPEV) Is Considered a Good Investment by Brokers: Is That True? - Finviz
XPeng (XPEV) Viewed Favorably by Analysts: Does the Claim Hold Up? - Bitget
XPENG (NYSE:XPEV) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Why XPeng, Inc. ADR Shares Are Surging Now - TipRanks
Consumer Tech News (March 2-6): Major Chip Earnings, Trump Refuted Negotiations With Anthropic AI & More - Benzinga
Huatai Securities Remains a Buy on XPeng, Inc. Class A (9868) - The Globe and Mail
XPeng (XPEV) Soars Ahead of Earnings; Q4 Deliveries Fall Short - Finviz
Buy, Hold or Sell NIO Stock? Key Insights Ahead of Q4 Earnings - Finviz
Analysts’ Opinions Are Mixed on These Consumer Cyclical Stocks: XPeng, Inc. ADR (XPEV), Ulta Beauty (ULTA) and ChargePoint Holdings (CHPT) - The Globe and Mail
XPeng Inc. Board Meeting and Q4/Fiscal Year 2025 Earnings Release, Conference Call Details Announced - Minichart
Analysts Conflicted on These Consumer Cyclical Names: XPeng, Inc. ADR (XPEV) and Norwegian Cruise Line (NCLH) - The Globe and Mail
He Xiaopeng: XPENG-W to Skip L3-lv. Autonomous Driving, Directly Deploy L4 Mass Production; Annual R&D Investment Expected to Be >RMB4.5B - AASTOCKS.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XPeng Inc.XPEV - ChartMill
XPENG (NYSE:XPEV) Sets New 52-Week LowWhat's Next? - MarketBeat
NIO, XPeng & Li Auto Post Delivery Results for February - TradingView
XPeng (NYSE: XPEV) posts 15,256 February EV deliveries, starts P7+ rollout - Stock Titan
XPENG-W Feb New Car Deliveries Drop 49.9% YoY to 15,256 Units - AASTOCKS.com
XPENG Announces Vehicle Delivery Results for February 2026 - The Manila Times
Bank of America Securities Sticks to Its Buy Rating for XPeng, Inc. ADR (XPEV) - The Globe and Mail
XPeng Inc. (XPEV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
What Does the Street Think About XPeng Inc. (XPEV)? - Finviz
Tesla Rival Xpeng Expands Robotics Bet With Guangzhou Factory For Optimus Challenger IRON - Benzinga
Why XPeng, Inc. ADR Shares Are Taking Off - TipRanks
XPeng CEO Targets Doubling Overseas Sales This Yr, 70%+ Profit Contribution from Overseas Mkts by 2030 - AASTOCKS.com
HSBC Research Favors XPENG-W, HORIZONROBOT-W as CN Improving Autonomous Driving Legal Framework - AASTOCKS.com
Citi is Bullish on XPeng Inc. (XPEV) - Finviz
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XPeng Inc. (XPEV) And Encourages Shareholders to Reach Out - ACCESS Newswire
XPeng Inc. (XPEV) Expands Charging and Global EV Presence - Finviz
Wall Street Analysts See XPeng (XPEV) as a Buy: Should You Invest? - Finviz
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against XPeng Inc. (XPEV) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Barclays sees downside risk for XPeng stock after low delivery numbers in January - Investing.com India
Pomerantz Law Firm Investigates Claims On Behalf of Investors of XPeng Inc.XPEV - marketscreener.com
XPENG Inc. Sponsored ADR (NYSE:XPEV) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
CLSA Slashes XPENG-W's TP to HKD77 as Rising Costs Delay Breakeven - AASTOCKS.com
XPeng (XPEV) Draws Mixed Analyst Calls, Expands Global Payments - Finviz
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against XPeng Inc. (XPEV) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
XPeng Inc. sponsored ADR (XPEV) stock sinks as market gains: Here's why - MSN
XPeng Inc. (XPEV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
As NIO Eyes Adjusted Operating Profit in Q4, Is the Stock a Buy Now? - Finviz
XPENG-W Announces Patent Related to Humanoid Robot Control - AASTOCKS.com
Finanzdaten der Xpeng Inc Adr-Aktie (XPEV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.44%
4.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):